CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C05004 | BRD-K08219523 | 5-nonyloxytryptamine | -- | -- | 5-NONYLOXYTRYPTAMINE | Details |
| C05005 | BRD-K08219814 | BRD-K08219814 | -- | -- | -- | Details |
| C05006 | BRD-K08220319 | BRD-K08220319 | -- | -- | -- | Details |
| C05007 | BRD-K08221563 | BRD-K08221563 | -- | -- | -- | Details |
| C05008 | BRD-K08227907 | 6-nitrodopamine | -- | -- | 6-NITRODOPAMINE | Details |
| C05009 | BRD-K08229828 | mevastatin | HMGCR | HMGCR inhibitor | -- | Details |
| C05010 | BRD-K08233096 | BRD-K08233096 | -- | -- | -- | Details |
| C05011 | BRD-K08240821 | BRD-K08240821 | -- | -- | -- | Details |
| C05012 | BRD-K08241590 | BRD-K08241590 | -- | -- | -- | Details |
| C05013 | BRD-K08246588 | BRD-K08246588 | -- | -- | -- | Details |
| C05014 | BRD-K08247301 | BRD-K08247301 | -- | -- | -- | Details |
| C05015 | BRD-K08247496 | BRD-K08247496 | -- | -- | -- | Details |
| C05016 | BRD-K08248804 | LCL-161 | -- | -- | -- | Details |
| C05017 | BRD-K08251038 | BRD-K08251038 | -- | -- | -- | Details |
| C05018 | BRD-K08252256 | diclofenac | PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
| C05019 | BRD-K08259535 | BRD-K08259535 | -- | -- | -- | Details |
| C05020 | BRD-K08260539 | BRD-K08260539 | -- | -- | -- | Details |
| C05021 | BRD-K08262651 | BRD-K08262651 | -- | -- | -- | Details |
| C05022 | BRD-K08266813 | BRD-K08266813 | -- | -- | -- | Details |
| C05023 | BRD-K08273968 | griseofulvin | -- | -- | -- | Details |
| C05024 | BRD-K08287586 | butylparaben | -- | -- | butyl-paraben | Details |
| C05025 | BRD-K08288431 | BRD-K08288431 | -- | -- | -- | Details |
| C05026 | BRD-K08290224 | docebenone | -- | -- | -- | Details |
| C05027 | BRD-K08293924 | BRD-K08293924 | -- | -- | -- | Details |
| C05028 | BRD-K08300592 | BRD-K08300592 | -- | -- | -- | Details |
| C05029 | BRD-K08303368 | chlorpyrifos | -- | -- | -- | Details |
| C05030 | BRD-K08306736 | BRD-K08306736 | -- | -- | -- | Details |
| C05031 | BRD-K08307026 | BRD-K08307026 | -- | -- | -- | Details |
| C05032 | BRD-K08308527 | BRD-K08308527 | -- | -- | -- | Details |
| C05033 | BRD-K08310154 | AG-1024 | IGF1R | IGF-1 inhibitor | -- | Details |
| C05034 | BRD-K08311368 | BRD-K08311368 | -- | -- | -- | Details |
| C05035 | BRD-K08311783 | BRD-K08311783 | -- | -- | -- | Details |
| C05036 | BRD-K08316444 | rotenone | ND1 | Mitochondrial complex I inhibitor | -- | Details |
| C05037 | BRD-K08317416 | BRD-K08317416 | -- | -- | -- | Details |
| C05038 | BRD-K08318631 | BRD-K08318631 | -- | -- | -- | Details |
| C05039 | BRD-K08325197 | BRD-K08325197 | -- | -- | -- | Details |
| C05040 | BRD-K08325710 | BRD-K08325710 | -- | -- | -- | Details |
| C05041 | BRD-K08327065 | kanamycin | -- | -- | -- | Details |
| C05042 | BRD-K08339178 | BRD-K08339178 | -- | -- | -- | Details |
| C05043 | BRD-K08340668 | BRD-K08340668 | -- | -- | -- | Details |
| C05044 | BRD-K08351986 | BRD-K08351986 | -- | -- | -- | Details |
| C05045 | BRD-K08353229 | BRD-K08353229 | -- | -- | -- | Details |
| C05046 | BRD-K08355771 | BRD-K08355771 | -- | -- | -- | Details |
| C05047 | BRD-K08356259 | xylometazoline | ADRA2A; ADRA2B; ADRA2C | Adrenergic receptor agonist | -- | Details |
| C05048 | BRD-K08359838 | BRD-K08359838 | -- | -- | -- | Details |
| C05049 | BRD-K08369728 | BRD-K08369728 | -- | -- | -- | Details |
| C05050 | BRD-K08371414 | BRD-K08371414 | -- | -- | -- | Details |
| C05051 | BRD-K08372451 | BG-1003 | -- | -- | -- | Details |
| C05052 | BRD-K08373870 | BRD-K08373870 | -- | -- | -- | Details |
| C05053 | BRD-K08377525 | BRD-K08377525 | -- | -- | -- | Details |
| C05054 | BRD-K08378202 | BRD-K08378202 | -- | -- | -- | Details |
| C05055 | BRD-K08388529 | BRD-K08388529 | -- | -- | -- | Details |
| C05056 | BRD-K08389119 | BRD-K08389119 | -- | -- | -- | Details |
| C05057 | BRD-K08389897 | BRD-K08389897 | -- | -- | -- | Details |
| C05058 | BRD-K08394807 | BRD-K08394807 | -- | -- | -- | Details |
| C05059 | BRD-K08403039 | BRD-K08403039 | -- | -- | -- | Details |
| C05060 | BRD-K08406395 | BRD-K08406395 | -- | -- | -- | Details |
| C05061 | BRD-K08408085 | BRD-K08408085 | -- | -- | -- | Details |
| C05062 | BRD-K08409548 | BRD-K08409548 | -- | -- | -- | Details |
| C05063 | BRD-K08412560 | BRD-K08412560 | -- | -- | -- | Details |
| C05064 | BRD-K08416835 | BRD-K08416835 | -- | -- | -- | Details |
| C05065 | BRD-K08416880 | BRD-K08416880 | -- | -- | -- | Details |
| C05066 | BRD-K08417745 | SID-26681509 | CTSL | Cathepsin inhibitor | -- | Details |
| C05067 | BRD-K08427390 | BRD-K08427390 | -- | -- | -- | Details |
| C05068 | BRD-K08428488 | BRD-K08428488 | -- | -- | -- | Details |
| C05069 | BRD-K08431704 | BRD-K08431704 | -- | -- | -- | Details |
| C05070 | BRD-K08432506 | BRD-K08432506 | -- | -- | -- | Details |
| C05071 | BRD-K08433493 | BRD-K08433493 | -- | -- | -- | Details |
| C05072 | BRD-K08436070 | BRD-K08436070 | -- | -- | -- | Details |
| C05073 | BRD-K08438266 | BRD-K08438266 | -- | -- | -- | Details |
| C05074 | BRD-K08438429 | BRD-K08438429 | GBA; SSTR4 | Somatostatin receptor agonist | -- | Details |
| C05075 | BRD-K08442552 | BRD-K08442552 | -- | -- | -- | Details |
| C05076 | BRD-K08443710 | BRD-K08443710 | -- | -- | -- | Details |
| C05077 | BRD-K08446420 | BRD-K08446420 | -- | -- | -- | Details |
| C05078 | BRD-K08446710 | BRD-K08446710 | -- | -- | -- | Details |
| C05079 | BRD-K08447949 | BRD-K08447949 | -- | -- | -- | Details |
| C05080 | BRD-K08448573 | BRD-K08448573 | -- | -- | -- | Details |
| C05081 | BRD-K08451418 | BRD-K08451418 | -- | -- | -- | Details |
| C05082 | BRD-K08458391 | BRD-K08458391 | -- | -- | -- | Details |
| C05083 | BRD-K08460070 | BRD-K08460070 | -- | -- | -- | Details |
| C05084 | BRD-K08461556 | BRD-K08461556 | -- | -- | -- | Details |
| C05085 | BRD-K08463963 | BRD-K08463963 | -- | -- | -- | Details |
| C05086 | BRD-K08464293 | BRD-K08464293 | -- | -- | -- | Details |
| C05087 | BRD-K08468228 | BRD-K08468228 | -- | -- | -- | Details |
| C05088 | BRD-K08472586 | BRD-K08472586 | -- | -- | -- | Details |
| C05089 | BRD-K08476323 | BRD-K08476323 | -- | -- | -- | Details |
| C05090 | BRD-K08477148 | BRD-K08477148 | -- | -- | -- | Details |
| C05091 | BRD-K08478539 | SMER-28 | -- | -- | -- | Details |
| C05092 | BRD-K08482401 | BRD-K08482401 | -- | -- | -- | Details |
| C05093 | BRD-K08486545 | cymarin | ATP1A1 | ATPase inhibitor | -- | Details |
| C05094 | BRD-K08489825 | BRD-K08489825 | -- | -- | -- | Details |
| C05095 | BRD-K08493205 | salicyl-alcohol | -- | -- | -- | Details |
| C05096 | BRD-K08502366 | BRD-K08502366 | -- | -- | -- | Details |
| C05097 | BRD-K08502430 | angiogenesis-inhibitor | EGFR | Angiogenesis inhibitor | -- | Details |
| C05098 | BRD-K08504955 | BRD-K08504955 | -- | -- | -- | Details |
| C05099 | BRD-K08508488 | BRD-K08508488 | -- | -- | -- | Details |
| C05100 | BRD-K08514109 | BRD-K08514109 | -- | -- | -- | Details |
| C05101 | BRD-K08519668 | BRD-K08519668 | -- | -- | -- | Details |
| C05102 | BRD-K08520424 | BRD-K08520424 | -- | -- | -- | Details |
| C05103 | BRD-K08521815 | BRD-K08521815 | -- | -- | -- | Details |